Ariad Pharmaceuticals, Inc. (ARIA) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $26.03 --0%
Financial Fact:
Net income (loss) per share - basic: -0.14
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Net income (loss) per share - basic: -0.14
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) reported Q3 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $25.1 million versus the consensus estimate of $26.13 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Exchange Traded Concepts and ARIAM Global launch ARIA an Actively Managed ETF Led by a Portfolio Manager with a Ph.D. in AI and Computer Science
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
